Trial intelligence / Profile preview

N-acetylcysteine for Prevention of Thrombotic Events After Allo-HSCT

NCT05907486Phase 3Not yet recruiting

Sponsor
First Affiliated Hospital of Soochow University
Start
Aug 2023
Primary completion
Aug 2025
Modality
Small Molecules
01

Overview

A Phase 3 trial of acetylcysteine in thrombotic disorders, sponsored by First Affiliated Hospital of Soochow University. Planned start Aug 2023; status: not yet recruiting.

02

Drugs

acetylcysteine
03

Conditions

thrombotic disorders

Beyond the preview

Go deeper on NCT05907486.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05907486.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call